• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在第一波 COVID-19 后,在 Thomayer 大学医院工作人员中 SARS-COV-2 抗体的流行率。

Prevalence of SARS-COV-2 antibodies in the Thomayer University Hospital staff after the first wave of COVID-19.

出版信息

Epidemiol Mikrobiol Imunol. 2022 Spring;71(1):3-8.

PMID:35477265
Abstract

OBJECTIVES

To map the prevalence of SARS-CoV-2 antibodies in the staff of the Thomayer University Hospital in Prague following the first wave of COVID-19. The main reason was the large number of COVID-19 patients admitted to the Thomayer University Hospital with confirmed SARS-CoV-2 infection.

MATERIAL AND METHODS

A volunteer study based on a questionnaire survey and determination of total antibodies (ECLIA, Roche) and individual classes of immunoglobulins (ELISA IgG and IgA, Euroimmun).

RESULTS

The study involved 808 employees, 2/3 of whom were from clinical departments. Fifteen participants, predominantly nurses (n = 12), tested ECLIA positive for antibodies against SARS-CoV-2 and ELISA positive or borderline positive for IgG antibodies. Positive or borderline IgA antibodies were recorded in 12 subjects. Most of the positive study participants (n = 13) contracted the SARS-CoV-2 virus at the workplace after repeated contact with positive patients. Most subjects infected (n = 12) had a more severe course but did not require hospitalization. We detected only one asymptomatic antibody-positive person.

CONCLUSIONS

After the first wave of COVID-19, SARS-CoV-2 antibodies were only demonstrated in 1.9% of the Thomayer University Hospital employees tested. In clinical departments, the positivity rate was 2.3%, and in non-clinical departments, it was only 0.5%. The low prevalence of antibodies points to the low number of infected hospital staff and a very good level of compliance with all public health and epidemiological measures.

摘要

目的

在 COVID-19 第一波疫情后,调查布拉格托马斯大学医院员工中 SARS-CoV-2 抗体的流行情况。主要原因是大量 COVID-19 患者被收入确诊 SARS-CoV-2 感染的托马斯大学医院。

材料与方法

这是一项基于问卷调查和总抗体(ECLIA,罗氏)及各免疫球蛋白类(ELISA IgG 和 IgA,欧蒙)测定的志愿者研究。

结果

该研究共纳入 808 名员工,其中 2/3 来自临床科室。15 名参与者(主要为护士,n=12)经 ECLIA 检测 SARS-CoV-2 抗体阳性,ELISA 检测 IgG 抗体阳性或边界阳性。12 名参与者的 IgA 抗体呈阳性或边界阳性。13 名阳性研究参与者(n=13)在反复接触阳性患者后于工作场所感染 SARS-CoV-2 病毒。大多数感染患者(n=12)的病情较为严重,但无需住院治疗。我们仅发现 1 名无症状抗体阳性者。

结论

COVID-19 第一波疫情后,仅在 1.9%接受检测的托马斯大学医院员工中发现 SARS-CoV-2 抗体。在临床科室中,阳性率为 2.3%,而非临床科室仅为 0.5%。抗体阳性率较低表明院内感染员工人数较少,且所有公共卫生和流行病学措施的遵守情况非常好。

相似文献

1
Prevalence of SARS-COV-2 antibodies in the Thomayer University Hospital staff after the first wave of COVID-19.在第一波 COVID-19 后,在 Thomayer 大学医院工作人员中 SARS-COV-2 抗体的流行率。
Epidemiol Mikrobiol Imunol. 2022 Spring;71(1):3-8.
2
Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.接触 SARS-CoV-2 疫情的医院工作人员的症状和免疫球蛋白发展情况。
Pediatr Allergy Immunol. 2020 Oct;31(7):841-847. doi: 10.1111/pai.13278. Epub 2020 Jun 18.
3
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.在医院环境中评估羟氯喹化学预防 SARS-CoV2 感染在医护人员中的疗效和安全性的对照、双盲、随机试验:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):472. doi: 10.1186/s13063-020-04400-4.
4
The level of protective post-vaccination antibodies in NIPH-NIH employees after administration of Pfizer vaccine against COVID-19.辉瑞 COVID-19 疫苗接种后日本国立感染症研究所-国立卫生研究所员工的保护性疫苗接种后抗体水平。
Przegl Epidemiol. 2021;75(1):3-13. doi: 10.32394/pe.75.01.
5
Testing for COVID-19: a few points to remember.新冠病毒检测:几点需要记住的事项。
Cas Lek Cesk. 2020 Spring;159(2):72-77.
6
Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.四种 SARS-CoV-2 抗体检测试剂在 COVID-19 患者及细菌性和非 SARS-CoV-2 病毒呼吸道感染患者中的诊断性能比较。
Eur J Clin Microbiol Infect Dis. 2021 Sep;40(9):1983-1997. doi: 10.1007/s10096-021-04285-4. Epub 2021 Jun 9.
7
[The prevalence rate of anti-SARS-CoV-2-IgG is 1.2% - Screening in asymptomatic outpatients in Germany (Northrhine-Westfalia)].[抗SARS-CoV-2-IgG的流行率为1.2%——德国(北莱茵-威斯特法伦州)无症状门诊患者筛查]
MMW Fortschr Med. 2020 Aug;162(14):44-46. doi: 10.1007/s15006-020-0750-y.
8
Prevalence of Health Care and Hospital Worker SARS-CoV-2 IgG Antibody in a Pediatric Hospital.儿科医院卫生保健和医院工作人员中 SARS-CoV-2 IgG 抗体的流行情况。
Hosp Pediatr. 2021 Mar;11(3):e48-e53. doi: 10.1542/hpeds.2020-003517. Epub 2020 Dec 23.
9
SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.COVID-19 大流行第一波期间考纳斯医院医护人员中 SARS-CoV-2 的血清流行率。
Medicina (Kaunas). 2021 Feb 6;57(2):148. doi: 10.3390/medicina57020148.
10
Infection Control Measures and Prevalence of SARS-CoV-2 IgG among 4,554 University Hospital Employees, Munich, Germany.德国慕尼黑大学附属医院 4554 名员工的感染控制措施和 SARS-CoV-2 IgG 流行率。
Emerg Infect Dis. 2022 Mar;28(3):572-581. doi: 10.3201/eid2803.204436.